West Pharmaceutical Services Inc. ($WST) Stock Forecast: Up 10.7% Today

What is West Pharmaceutical Services Inc.?

West Pharmaceutical Services, Inc. (WST) is a global manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The company has been experiencing strong demand and growth in its Proprietary Products segment.

Why is West Pharmaceutical Services Inc. going up?

WST stock is up 10.7% on Oct 23, 2025 18:41

• WST stock experienced a bullish movement today due to the company's strong Q3 earnings beat and raised EPS outlook, driven by robust demand and favorable foreign exchange rates.
• The market responded positively to the company's solid growth in Proprietary Products, reflecting investors' confidence in West Pharmaceutical's ability to capitalize on market opportunities.
• Despite potential challenges such as labor constraints, tariffs, and plant shutdowns, the momentum in GLP-1 and biologics demand seems to have outweighed any margin pressure concerns, further boosting investor sentiment towards WST stock.

WST Price Chart

WST Technical Analysis

WST News

WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit

West Pharmaceutical's strong Q3 beat and raised EPS outlook highlight robust demand, FX tailwinds, and solid growth in Proprietary Products.

https://www.zacks.com/stock/news/2775686/wst-stock-up-on-q3-earnings-beat-eps-view-raised-on-demand-fx-benefit

WST Q3 Earnings Preview: Can GLP-1 Momentum Outweigh Margin Pressure?

West Pharma's Q3 numbers hinge on robust GLP-1 and biologics demand, but labor constraints, tariffs, and plant shutdowns could test its margin resilience.

https://www.zacks.com/stock/news/2770951/wst-q3-earnings-preview-can-glp-1-momentum-outweigh-margin-pressure

Trending Today

Internet Computer ($ICP) Crypto Forecast: Up 18.4% Today

Plug Power Inc. ($PLUG) Stock Forecast: Up 5.3% Today

Zimmer Biomet Holdings Inc. ($ZBH) Stock Forecast: Down 15.5% Today

Credo Technology Group ($CRDO) Stock Forecast: Up 5.2% Today

Robinhood Inc. ($HOOD) Stock Forecast: Up 5.1% Today

Humana Inc. ($HUM) Stock Forecast: Down 7.3% Today

Johnson Controls International plc ($JCI) Stock Forecast: Up 9.4% Today

Cardano ($ADA) Crypto Forecast: Up 6.5% Today

Ethereum ($ETH) Crypto Forecast: Up 8.6% Today

Rivian Automotive Inc. ($RIVN) Stock Forecast: Up 23.8% Today

West Pharmaceutical Services Inc. Price History

03.00.2025 - WST Stock was up 3.6%

• Investors may have perceived WST's value favorably compared to its competitor Labcorp (LH).
• The contrast between LH and WST could have positioned WST as an underestimated stock, appealing to more investors.
• This positive perception of WST's value proposition likely contributed to the bullish performance of the stock today.

24.06.2025 - WST Stock was up 23.7%

• WST stock surged as the company reported a strong Q2 earnings beat, driven by an increase in earnings per share due to tariff and foreign exchange benefits.
• Revenue growth in the Proprietary Products segment played a key role in the positive market movement, signaling robust demand for high-value products like GLP-1 and SmartDose.
• Investor sentiment remains upbeat about West Pharmaceutical's ability to sustain growth in Q2, buoyed by ongoing strength in critical segments.
• Bullish investor confidence today was likely strengthened by the favorable earnings outlook and segmental performance expectations for West Pharmaceutical Services, Inc.

06.05.2025 - WST Stock was up 5.5%

• The bullish movement in WST stock could be attributed to investors' optimism regarding the pending class action lawsuit.
• The reminder of the lawsuit deadline might have sparked confidence in the market, indicating that the company is taking necessary legal actions to address any potential issues.
• This proactive approach from West Pharmaceutical Services, Inc. could have reassured investors and led to increased buying interest, driving the stock price higher.
• Overall, the market's positive reaction to the news of the pending class action lawsuit reflects investor confidence in the company's ability to handle legal challenges effectively.

24.01.2025 - WST Stock was up 5.3%

• WST experienced a bullish movement due to its identification as one of the top health care stocks with considerable growth potential this month.
• The stock being oversold in the health care sector attracted investors seeking undervalued opportunities.
• The Relative Strength Index (RSI), a momentum indicator, boosted trader confidence, resulting in increased buying pressure and a rise in the stock price.
• Positive market sentiment towards the health care sector and specific company analysis likely played a role in the notable bullish movement observed in WST.

13.01.2025 - WST Stock was down 32.6%

• Despite a positive performance in West Pharmaceutical's Q4 earnings, the stock showed a drop in pre-market trading.
• The decline in margins is considered a possible factor in the bearish movement, despite an increase in revenue in the Proprietary Products segment.
• Investors seemed to place more emphasis on the margin decrease rather than the overall earnings beat, resulting in a pessimistic market outlook and the downward trend in the stock price.

23.06.2025 - WST Stock was up 5.3%

• WST's strong bullish movement today could be attributed to the market's anticipation of steady growth in Q2 earnings, driven by the high demand for GLP-1 and SmartDose products.
• Investors may be optimistic about WST's segmental edge holding up, leading to increased confidence in the company's performance.
• The focus on innovation and meeting the demand for healthcare products could be positioning WST favorably in the market, attracting investor interest and driving the stock's upward movement.

10.06.2025 - WST Stock was up 4.0%

• The rise in WST's stock price could be due to investors' growing confidence in the company's ability to manage the class action lawsuit situation.
• Initially, the announcement of investors having the chance to lead a class action lawsuit caused uncertainty and a decrease in the stock price.
• However, as more investors engage legal support to discuss their rights before the deadline, it suggests a potential positive resolution for the company, leading to the stock's upward movement.
• This scenario emphasizes the significance of monitoring legal developments and investor sentiment alongside the company's operational performance when evaluating stock fluctuations.

04.03.2025 - WST Stock was down 6.5%

• Despite the positive surge in ProDex (PDEX) stock, WST experienced a bearish movement.
• The lack of indication for further gains in ProDex might have caused investors to reallocate their funds, leading to a sell-off in WST.
• Investors may have shifted focus from WST to ProDex, anticipating better returns based on the recent surge in PDEX stock price.
• This shift in market sentiment towards ProDex could have contributed to the bearish movement in WST as investors sought potentially more lucrative opportunities in the market.

22.03.2025 - WST Stock was up 5.4%

• WST had a strong bullish movement today due to expectations of strong segmental performance in the first quarter, driven by growth in pharmaceutical stabilization, biologics rebound, and contract manufacturing gains.
• The market is likely reacting positively to the potential growth and stability in the pharmaceutical sector, which is a key market for West Pharmaceutical Services.
• Investors are optimistic about the company's ability to capitalize on the increased demand for injectable drug administration solutions, especially in the current global health landscape.

13.01.2025 - WST Stock was down 35.7%

• Despite exceeding Q4 earnings expectations, West Pharmaceutical's stock experienced a decline attributed to weaker-than-anticipated guidance for 2025. This included adjusted EPS and revenue forecasts that missed consensus estimates.
• The market responded negatively to the company's reduced earnings and revenue projections for the upcoming year, resulting in a notable sell-off of WST stock.
• Investors reacted possibly due to disappointment stemming from the downward revision in West Pharmaceutical's future financial outlook. This sentiment drove the stock price lower during today's trading session.

23.09.2025 - WST Stock was up 14.5%

• The bullish movement in WST could be attributed to the anticipation of strong Q3 earnings driven by robust demand for GLP-1 and biologics products.
• Investors seem optimistic about WST's ability to navigate challenges such as labor constraints, tariffs, and plant shutdowns, which might have positively impacted the stock price.
• The market may be pricing in the potential for WST to outperform expectations despite margin pressures, showcasing confidence in the company's resilience and growth prospects.

23.09.2025 - WST Stock was up 10.7%

• WST stock experienced a bullish movement today due to the company's strong Q3 earnings beat and raised EPS outlook, driven by robust demand and favorable foreign exchange rates.
• The market responded positively to the company's solid growth in Proprietary Products, reflecting investors' confidence in West Pharmaceutical's ability to capitalize on market opportunities.
• Despite potential challenges such as labor constraints, tariffs, and plant shutdowns, the momentum in GLP-1 and biologics demand seems to have outweighed any margin pressure concerns, further boosting investor sentiment towards WST stock.